Stay updated on PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial
Sign up to get notified when there's something new on the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page.

Latest updates to the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page
- Check6 days agoChange DetectedA new revision entry v3.5.5 appears in the page's revision history. The previous entry v3.5.4 is removed from the history list.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page's revision history now lists v3.5.4 as the latest revision, replacing the previous v3.5.3.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page footer’s software/version indicator is updated from Revision v3.5.2 to Revision v3.5.3, reflecting a maintenance or release update rather than a change to the trial record itself.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision history now includes v3.5.2 and removes v3.5.0.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed from the study history.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision v3.4.3 was added to the study record history and Revision v3.4.2 was removed.SummaryDifference0.1%

Stay in the know with updates to PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page.